Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irena Dumalakiene

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Clinical & Developmental Immunology|January 21, 2012
Expression of IL-17, IL-23 and their receptors in minor salivary glands of patients with primary Sjögren's syndromeDiana Mieliauskaite, Irena Dumalakiene, Rita Rugiene, et al.
Epilepsy & Behavior : E&B|October 30, 2012
Melatonin secretion in children with epilepsyRuta Praninskiene, Irena Dumalakiene, Robertas Kemezys, et al.
Autoimmunity|October 9, 2009
Relationship between serum levels of TGF-beta1 and clinical parameters in patients with rheumatoid arthritis and Sjögren's syndrome secondary to rheumatoid arthritisDiana Mieliauskaite, Paulius Venalis, Irena Dumalakiene, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|September 24, 2022
The significance of TNF-α and MMP-8 concentrations in non-invasively obtained amniotic fluid predicting fetal inflammatory response syndromeVioleta Gulbiniene, Greta Balciuniene, Irena Dumalakiene, et al.
In Vivo (Athens, Greece)|February 21, 2013
Activity of T-helper cells in patients with primary Sjogren's syndromeGintaras Sudzius, Diana Mieliauskaite, Irena Butrimiene, et al.
Rheumatology International|October 30, 2013
Could the complement component C4 or its fragment C4d be a marker of the more severe conditions in patients with primary Sjögren's syndrome?Gintaras Sudzius, Diana Mieliauskaite, Almantas Siaurys, et al.
Journal of Immunology Research|June 20, 2015
Distribution of Peripheral Lymphocyte Populations in Primary Sjögren's Syndrome PatientsGintaras Sudzius, Diana Mieliauskaite, Almantas Siaurys, et al.
International Journal of Molecular Sciences|March 25, 2022
The Significance of Epidermal Growth Factor in Noninvasively Obtained Amniotic Fluid Predicting Respiratory Outcomes of Preterm NeonatesVioleta Gulbiniene, Greta Balciuniene, Justina Petroniene, et al.
Cellular Immunology|September 5, 2016
Are cytotoxic effector cells changes in peripheral blood of patients with Sjögren's syndrome related to persistent virus infection: Suggestions and conundrumsIeva Narkeviciute, Gintaras Sudzius, Diana Mieliauskaite, et al.
The Libyan Journal of Medicine|October 29, 2013
Leukocytosis as a prognostic marker in the development of fetal inflammatory response syndromeDaiva Bartkeviciene, Ingrida Pilypiene, Grazina Drasutiene, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Clinical & Developmental Immunology|January 21, 2012
Expression of IL-17, IL-23 and their receptors in minor salivary glands of patients with primary Sjögren's syndromeDiana Mieliauskaite, Irena Dumalakiene, Rita Rugiene, et al.
Epilepsy & Behavior : E&B|October 30, 2012
Melatonin secretion in children with epilepsyRuta Praninskiene, Irena Dumalakiene, Robertas Kemezys, et al.
Autoimmunity|October 9, 2009
Relationship between serum levels of TGF-beta1 and clinical parameters in patients with rheumatoid arthritis and Sjögren's syndrome secondary to rheumatoid arthritisDiana Mieliauskaite, Paulius Venalis, Irena Dumalakiene, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|September 24, 2022
The significance of TNF-α and MMP-8 concentrations in non-invasively obtained amniotic fluid predicting fetal inflammatory response syndromeVioleta Gulbiniene, Greta Balciuniene, Irena Dumalakiene, et al.
In Vivo (Athens, Greece)|February 21, 2013
Activity of T-helper cells in patients with primary Sjogren's syndromeGintaras Sudzius, Diana Mieliauskaite, Irena Butrimiene, et al.
Rheumatology International|October 30, 2013
Could the complement component C4 or its fragment C4d be a marker of the more severe conditions in patients with primary Sjögren's syndrome?Gintaras Sudzius, Diana Mieliauskaite, Almantas Siaurys, et al.
Journal of Immunology Research|June 20, 2015
Distribution of Peripheral Lymphocyte Populations in Primary Sjögren's Syndrome PatientsGintaras Sudzius, Diana Mieliauskaite, Almantas Siaurys, et al.
International Journal of Molecular Sciences|March 25, 2022
The Significance of Epidermal Growth Factor in Noninvasively Obtained Amniotic Fluid Predicting Respiratory Outcomes of Preterm NeonatesVioleta Gulbiniene, Greta Balciuniene, Justina Petroniene, et al.
Cellular Immunology|September 5, 2016
Are cytotoxic effector cells changes in peripheral blood of patients with Sjögren's syndrome related to persistent virus infection: Suggestions and conundrumsIeva Narkeviciute, Gintaras Sudzius, Diana Mieliauskaite, et al.
The Libyan Journal of Medicine|October 29, 2013
Leukocytosis as a prognostic marker in the development of fetal inflammatory response syndromeDaiva Bartkeviciene, Ingrida Pilypiene, Grazina Drasutiene, et al.
Pageof 2